Q3 2017


Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam ultricies neque sit amet tortor malesuada tristique. Suspendisse cursus scelerisque lacus, sit amet mollis mi hendrerit non. Mauris at imperdiet libero. Vestibulum commodo ex lorem, ac tincidunt lectus pharetra vel. Vivamus ut lacus sed tortor commodo bibendum. Morbi ultrices elit ac purus egestas vestibulum. Nam consectetur malesuada ipsum, sit amet mattis lorem iaculis at.


Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam ultricies neque sit amet tortor malesuada tristique. Suspendisse cursus scelerisque lacus, sit amet mollis mi hendrerit non. Mauris at imperdiet libero. Vestibulum commodo ex lorem, ac tincidunt lectus pharetra vel. Vivamus ut lacus sed tortor commodo bibendum. Morbi ultrices elit ac purus egestas vestibulum. Nam consectetur malesuada ipsum, sit amet mattis lorem iaculis at.

Global Landscape

843+

Regenerative Medicine Companies
Worldwide, Including Gene and
Cell Therapies

450North America21Oceania1Africa122Asia15South America15Europe & Israel

Financings

Total Q3 2017 Global Financings

Total Global Financing

102%

Increase from Q3 2016

100.0%010123456undefined
Gene & Gene-modified
Cell Therapy

167%

Increase from Q3 2016

100.0%0100.511.522.533.54undefined
Cell Therapy

295%

Increase from Q3 2016

100.0%0100.511.522.533.54undefined
Tissue Engineering

79%

Decrease from Q3 2016

100.0%01050100150200250300undefined

Total Global Financings by Type, by Year

165322442216182196317615878476471183836105214326186556945191311IPOsFollow-OnsCorporate PartnershipsVenture CapitalPipesMergers & Acquisitions05001000150020002500300020152016As of Sept. 30 2017

934

Clinical trials underway
worldwide by the end of Q3 2017

PH. 1

307

PH. 2

548

PH. 3

79

100.0%0101020304050607080undefined

Clinical Trials

Number of Clinical Trials Utilizing Specific
RM / AT Technology: Q3 2017

Gene & Gene-modified
Cell Therapy
100.0%010510152025303540undefined
Cell Therapy
100.0%01051015202530354045undefined
Tissue Engineering
100.0%0100.511.522.533.54undefined

Clinical Trials by Indication: Q3 2017

Oncology
492
Cardiovascular
85
Central Nervous System
58
Musculoskeletal
54
Infectious Disease
37
Immunology & Inflammation
37
Endocrine Metabolic & Genetic Disorders
37
Dermatology
35
Ophthalmology
28
Hematology
24
Gastroenterology
12
Genitourinary Disorders
11
Respiratory
9
Surgery
6
Lymphatic Diseases
3
Ear Diseases
2
Radiation Injury
1
Geriatric Diseases
1